Cowen And Company »

Jasper Therapeutics shares owned by Cowen And Company

Quarter-by-quarter ownership of Jasper Therapeutics shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Jasper Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeutics held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeutics by Cowen And Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $158k 200k 0.79
2023-09-30 $140k 200k 0.70

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Ptc Therapeutics I (PTCT)
Coinbase Global Com Cl A (COIN)
Avidity Biosciences Ord (RNA)
Sirius Xm Holdings (SIRI)
Tarsus Pharmaceuticals (TARS)
Churchill Capital Corp Vii Com Cl A (CVII)
Immunocore Hldgs Ads (IMCR)
Select Sector Spdr Tr Energy (XLE)
Rocket Pharmaceuticals (RCKT)
Mercer International (MERC)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Sage Therapeutics (SAGE)
Alibaba Group Hldg Sponsored Ads (BABA)
Imperial Oil Com New (IMO)

View all positions for Cowen And Company

Top funds holding Jasper Therapeutics

Soleus Capital Management
Carlyle
Qiming U.S. Ventures Management
Octagon Capital Advisors
Vanguard Group
Opaleye Management
Kingdon Capital Management
Bank of America Corporation
Nantahala Capital Management
Landscape Capital Management
Sphera Funds Management
Mariner Wealth Advisors
Bank Of Montreal
Monaco Asset Management SAM
Citadel Advisors

View all funds holding Jasper Therapeutics